Key Insights of “Particle Therapy Market” to 2023 – Dominated by North America and Europe Region

Get Sample Research Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1778129

The Global Particle Therapy Market is projected to reach USD 1,349 Million by 2023 from USD 865 Million in 2018, at a CAGR of 9.3%. This report spread across 138 Pages, Profiling 10 Companies and Supported with 80 Tables and 36 figures are now available in this research.

 

Top Key Players Profiled in the Particle Therapy Market:

  • Ion Beam Applications SA (Belgium)
  • Varian Medical Systems Inc. (US)
  • Hitachi Ltd. (Japan)
  • Provision Healthcare (US)
  • Mevion Medical Systems Inc. (US)
  • Sumitomo Heavy Industries Ltd. (Japan)
  • Optivus Proton Therapy Inc. (US)
  • ProTom International Inc. (US)
  • Advanced Onco therapy Plc. (UK)
  • Danfysik A/S (Denmark)

 

Based on type, the particle therapy products market is segmented into cyclotrons, synchrotrons, and synchro cyclotrons. The cyclotrons segment is expected to account for the largest share of this market in 2018. The development of technologically advanced systems, advantages offered by cyclotrons over other accelerators, and the growing adoption of cyclotrons among users are the major factors driving the growth of this market segment.

 

Access full report with all information @ https://www.reportsnreports.com/purchase.aspx?name=1778129

 

The particle therapy market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is expected to account for the second-largest share of the global particle therapy market in 2018.Technological advancements in the field of particle therapy, the rising incidence of cancer, easy accessibility to treatments, and the high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure by the US and Canadian governments)are some of the key factors supporting the growth of the North American market.

 

Breakdown of primary participants’ profile:

  • By Company Type: Tier 1–25%, Tier 2–30%, and Tier 3–45%
  • By Designation:C-level–26%, Director-level–30%, and Others–44%
  • By Region: North America–35%, Europe–26%, APAC–23%, and RoW–16%

 

Competitive Landscape of Particle Therapy Market:

1 Introduction

2 Market Share Analysis

3 Competitive Scenario

3.1 Product Launches and Approvals

3.2 Acquisitions

3.3 Expansions

3.4 Agreements and Collaborations

 

Any Doubt or Need Customization Report @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1778129

Share This Post